16.07.2024 19:25 | LIKE, SOU, KINO | EARNINGS AND TRADING: Gateley earnings fall; 4Global revenue rises | Alliance |
16.07.2024 07:00 | CEL | Successful Completion of Eighth Harvest of 2024 | RNS |
15.07.2024 13:58 | CEL | Third Admission of Shares | RNS |
28.06.2024 07:00 | CEL | Result of AGM | RNS |
20.06.2024 15:48 | URAH, SIV, SQZ | UK shareholder meetings calendar - next 7 days | Alliance |
07.06.2024 07:00 | CEL | Second Admission of Shares | RNS |
03.06.2024 17:45 | CEL | Publication of Annual Report & Notice of AGM | RNS |
23.05.2024 21:08 | CEL, AET, PHAR | TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact | Alliance |
23.05.2024 07:00 | CEL | Supply of Products to New US Customer | RNS |
15.05.2024 14:45 | CEL | Exercise of Share Options and Total Voting Rights | RNS |
14.05.2024 19:41 | FDM, ZYT, CEL | TRADING UPDATES: Headlam warns of loss; EnSilica predicts revenue rise | Alliance |
14.05.2024 07:00 | CEL | Final Results | RNS |
10.05.2024 18:57 | CEL | IN BRIEF: Celadon raises GBP2 million, extends credit facility | Alliance |
10.05.2024 07:00 | CEL | Fundraise, RCF Extension, Termination of CLN & TVR | RNS |
08.03.2024 20:04 | RIO, TPOU, LST | TRADING UPDATES: Celadon hails early results of chronic pain trial | Alliance |
07.03.2024 07:00 | CEL | Early Economic Analysis of Feasibility Study Data | Reach |
14.12.2023 14:18 | CEL | Celadon announces start of cannabis supply for two UK companies | Alliance |
14.12.2023 07:00 | CEL | Product Supplied to First Two Sales Contracts | RNS |
12.12.2023 17:40 | ECO, CEL, CNR | TRADING UPDATES: Celadon Pharma raises GBP2.0 million via placing | Alliance |
12.12.2023 14:00 | CEL | Fundraise, Update on Future CLN Financing & TVR | RNS |
16.11.2023 11:45 | CEL | Celadon shares rise on supply contract worth up to GBP26 million | Alliance |
16.11.2023 07:00 | CEL | New European Sales Contract | RNS |
13.10.2023 15:42 | CEL | IN BRIEF: Celadon Pharmaceuticals raises GBP1.0 million through shares | Alliance |
13.10.2023 07:00 | CEL | Fundraise, CLN Issue, Joint Broker Appointed & TVR | RNS |
02.10.2023 09:06 | CEL, IHC, AMS | Advanced Medical Solutions appoints non-executive director as chair | Alliance |
28.09.2023 12:14 | CEL | Celadon Pharmaceuticals interim loss narrows; optimistic for future
| Alliance |
28.09.2023 07:00 | CEL | Interim Results | RNS |
21.09.2023 15:48 | XLM, TRIN, TRLS | UK earnings, trading statements calendar - next 7 days | Alliance |
18.09.2023 07:00 | CEL | Notice of Results and Investor Presentation | RNS |
05.09.2023 10:48 | CEL | Celadon shares rise on second UK contract win for cannabis product | Alliance |
05.09.2023 07:00 | CEL | New Sales Contract with UK Pharmaceutical Company | RNS |
01.08.2023 11:44 | CEL | Celadon receives approval for 5,000 patient clinical cannabis trial | Alliance |
01.08.2023 07:00 | CEL | Approval to roll-out chronic pain clinical trial | RNS |
29.06.2023 17:30 | CEL | Result of AGM | RNS |
22.06.2023 15:44 | VRCI, TRR, TXP | UK shareholder meetings calendar - next 7 days | Alliance |
05.06.2023 14:46 | CEL | Publication of Annual Report and Notice of AGM | RNS |
05.06.2023 12:23 | CEL | Celadon Pharmaceuticals loss widens; confident amid three-year deal | Alliance |
05.06.2023 07:00 | CEL | Final Results for the year ended 31 December 2022 | RNS |
30.05.2023 11:56 | CEL | Celadon secures GBP7 million credit facility as product demand grows | Alliance |
30.05.2023 07:00 | CEL | £7 Million Committed Credit Facility | RNS |
26.05.2023 07:00 | CEL | Notice of Results and Investor Presentation | RNS |
25.05.2023 07:00 | CEL | West Midlands Mayor Visits Celadon’s Facility | Reach |
24.05.2023 12:29 | CEL | CORRECT: Celadon signs commercial cannabis supply agreement in UK | Alliance |
24.05.2023 11:51 | CEL | Celadon signs commercial cannabis supply agreement with UK firm | Alliance |
24.05.2023 07:00 | CEL | Inaugural Supply Contract Win | RNS |
29.03.2023 11:05 | CEL | Second Price Monitoring Extn | RNS |
29.03.2023 11:00 | CEL | Price Monitoring Extension | RNS |
17.03.2023 21:10 | MODE, DNA2, CEL | TRADING UPDATES: Literacy Capital nets gain from investment disposal | Alliance |
17.03.2023 20:49 | MODE, DNA2, CEL | TRADING UPDATES: Literacy Capital nets gain from investment disposal | Alliance |
17.03.2023 16:35 | CEL | Price Monitoring Extension | RNS |
17.03.2023 14:05 | CEL | Second Price Monitoring Extn | RNS |
17.03.2023 14:00 | CEL | Price Monitoring Extension | RNS |
14.03.2023 15:01 | CEL | Successful Update to Home Office Licence | RNS |
14.03.2023 14:05 | CEL | Second Price Monitoring Extn | RNS |
14.03.2023 14:00 | CEL | Price Monitoring Extension | RNS |
13.03.2023 16:40 | CEL | Second Price Monitoring Extn | RNS |
13.03.2023 16:35 | CEL | Price Monitoring Extension | RNS |
13.03.2023 09:05 | CEL | Second Price Monitoring Extn | RNS |
13.03.2023 09:00 | CEL | Price Monitoring Extension | RNS |
10.03.2023 16:40 | CEL | Second Price Monitoring Extn | RNS |
10.03.2023 16:35 | CEL | Price Monitoring Extension | RNS |
10.03.2023 14:05 | CEL | Second Price Monitoring Extn | RNS |
10.03.2023 14:00 | CEL | Price Monitoring Extension | RNS |
10.02.2023 14:15 | CEL | Notification of transaction by PDMR | RNS |
19.01.2023 07:00 | CEL | Change of Website Address | RNS |
16.01.2023 13:25 | CEL | Celadon says UK Midlands manufacturing facility gets MHRA boost | Alliance |
16.01.2023 07:00 | CEL | Approval of GMP Registration by MHRA | RNS |
13.01.2023 10:28 | CEL | IN BRIEF: Celadon Pharmaceuticals formally confirms CFO appointment | Alliance |
13.01.2023 07:00 | CEL | Update on CFO Appointment | RNS |
30.12.2022 14:37 | ANIC, MSMN, CEL | TRADING UPDATES: Lansdowne extends loan, Celadon plans clinical trial | Alliance |
30.12.2022 07:00 | CEL | Results of Feasibility Study | RNS |
23.12.2022 17:05 | AERI, GUN, URU | TRADING UPDATES: Logistics Development buys Alliance Pharma shares | Alliance |
22.12.2022 07:00 | CEL | Update on GMP Registration by MHRA | RNS |
01.11.2022 15:34 | TLY, CEL, OXIG | EXECUTIVE CHANGES: Former 600 CFO to return; Celadon hires new CFO | Alliance |
01.11.2022 07:00 | CEL | Appointment of CFO | RNS |